Zentalis Pharmaceuticals Market Sentiment

Zentalis Pharmaceuticals Inc

ZNTLNASDAQ

$2.06

-0.01-0.48%

Últ. Act.: Oct 26, 7:44 PM

Panorámica general Noticias Previsión de beneficios Eventos Precios objetivo FinanzasSentimientoComparar Opciones Informe de acciones

Zentalis Pharmaceuticals Market Sentiment

Market sentiment signals for Zentalis Pharmaceuticals (ZNTL): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▼ 7.4% short float

Options Flow— N/A

Insider Activity— N/A

Analyst Consensus

Buy

14 analysts

Options Flow (P/C)

—

Avg Consensus PT

+318.9%

Highest Price Target

$20

+870.9%

Oppenheimer

Lowest Price Target

+6.8%

UBS

Short Interest

7.4%

Rising — Bearish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Oct 19, 2026	HC Wainwright & Co.	Andres Y. Maldonado—	+385.4%	$10 → $10	Maintained	Buy
Oct 5, 2026	Leerink Partners	Asthika Goonewardene—	+288.3%	$4 → $8	Assumes	Market Perform→Outperform
Sep 16, 2026	William Blair	Matt Phipps—	—	—	Initiate	Outperform
Jul 23, 2026	Rodman & Renshaw	——	+434.0%	$11	Initiate	Buy
Jul 17, 2026	Mizuho	Graig Suvannavejh—	+288.3%	$8	Initiate	Outperform
Apr 10, 2026	Guggenheim	Michael Schmidt—	+385.4%	$6 → $10	Maintained	Buy
Mar 27, 2026	Guggenheim	Michael Schmidt—	+191.3%	$6 → $6	Maintained	Buy
Nov 12, 2025	Morgan Stanley	Matthew Harrison—	+94.2%	$8 → $4	Maintained	Equal-Weight
Aug 7, 2025	Wells Fargo	Derek Archila—	+142.7%	$6 → $5	Maintained	Equal-Weight
May 15, 2025	Wedbush	Robert Driscoll—	+94.2%	$4 → $4	Maintained	Neutral
May 15, 2025	HC Wainwright & Co.	Andres Maldonado—	+385.4%	$10 → $10	Maintained	Buy
Mar 28, 2025	Wedbush	Robert Driscoll—	+94.2%	$4 → $4	Maintained	Neutral
Mar 27, 2025	HC Wainwright & Co.	Andrew Fein—	+385.4%	$10 → $10	Maintained	Buy
Mar 17, 2025	HC Wainwright & Co.	Andrew Fein—	+385.4%	$10 → $10	Maintained	Buy
Jan 30, 2025	Wells Fargo	Derek Archila—	+191.3%	$8 → $6	Maintained	Equal-Weight
Jan 29, 2025	HC Wainwright & Co.	Andrew Fein—	+385.4%	$20 → $10	Maintained	Buy
Jan 28, 2025	UBS	Eliana Merle—	+6.8%	$5 → $2	Maintained	Neutral
Nov 15, 2024	Guggenheim	Michael Schmidt—	+288.3%	$12 → $8	Maintained	Buy
Nov 15, 2024	HC Wainwright & Co.	Andrew Fein—	+870.9%	$20 → $20	Maintained	Buy
Sep 16, 2024	Oppenheimer	Matthew Biegler—	+870.9%	$20 → $20	Maintained	Outperform
Aug 12, 2024	Wedbush	Robert Driscoll—	+94.2%	$4	Upgrade	Underperform→Neutral
Aug 12, 2024	HC Wainwright & Co.	Andrew Fein—	+870.9%	$20 → $20	Maintained	Buy
Jun 20, 2024	UBS	Eliana Merle—	+142.7%	$28 → $5	Downgrade	Buy→Neutral
Jun 18, 2024	Wells Fargo	Derek Archila—	+336.9%	$29 → $9	Downgrade	Overweight→Equal-Weight
Jun 18, 2024	Stifel	Bradley Canino—	+385.4%	$32 → $10	Maintained	Buy